Review: Clomipramine is more effective than SSRIs for paediatric obsessive compulsive disorder: Commentary

Evidence-Based Mental Health

Volumn 7, Issue 2, 2004, Pages 50-

  March, John S ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79960459574     PISSN: 13620347     EISSN: None     Source Type: Journal    
DOI: 10.1136/ebmh.7.2.50     Document Type: Note

References (5)

1. March JS, Johnston H, Jefferson JW, et al. Do subtle neurological impairments predict treatment resistance to clomipramine in children and adolescents with obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 1990;1:133-40.
2. DeVeaugh-Geiss J, Moroz G, Biederman J, et al. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder: a multicenter trial. J Am Acad Child Adolesc Psychiatry 1992;31:45-9.
3. Franklin M, Foa E, March JS. The pediatric obsessive-compulsive disorder treatment study: rationale, design, and methods. J Child Adolesc Psychopharmacol 2003;13(Suppl 1):S39-51.
4. March J, Frances A, Kahn D, et al. Expert consensus guidelines: Treatment of obsessive-compulsive disorder. J Clin Psychiatry 1997;58:1-72.
5. March J, Mulle K. OCD in children and adolescents: a cognitive-behavioral treatment manual. New York: Guilford Press, 1998.